lobbying_activities: 3188466

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3188466	9528d989-d284-41c6-b726-dbfa319dd149	Q2	THE LIAISON GROUP, LLC	401104378	NATIONAL CANNABIS ROUNDTABLE	2024	second_quarter	CSP	Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office	65500		0	0	2024-07-11T09:53:01-04:00